New radiation regimen cuts treatment time for early glottic cancer

This study tests a shorter, higher-dose radiation schedule (3.5 Gy per fraction for 17 sessions) for people with early-stage glottic cancer (T1-T2N0M0). The goal is to see if this approach controls the tumor as well as standard longer radiation, while being more convenient. About 70 adults who have not had prior larynx surgery or radiation will participate. The main outcome measured is local tumor control.